HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yao-Ping Lu Selected Research

Aftercare (After-Treatment)

8/2005Administration of green tea or caffeine enhances the disappearance of UVB-induced patches of mutant p53 positive epidermal cells in SKH-1 mice.
7/2004Stimulatory effect of topical application of caffeine on UVB-induced apoptosis in the epidermis of p53 and Bax knockout mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yao-Ping Lu Research Topics

Disease

16Carcinogenesis
07/2014 - 08/2002
16Neoplasms (Cancer)
03/2014 - 08/2002
9Skin Neoplasms (Skin Cancer)
01/2014 - 09/2002
7Sunburn
01/2014 - 01/2002
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2014 - 09/2002
2Keratoacanthoma
02/2014 - 06/2012
2Obesity
11/2011 - 10/2006
2Ataxia Telangiectasia (Louis Bar Syndrome)
08/2011 - 04/2008
2Hyperplasia
03/2008 - 08/2005
1Melanoma (Melanoma, Malignant)
01/2013
1Fatty Liver
11/2011
1Body Weight (Weight, Body)
11/2011
1Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2011
1Insulin Resistance
11/2011

Drug/Important Bio-Agent (IBA)

17Caffeine (No Doz)FDA LinkGeneric
01/2014 - 01/2002
8TeaIBA
01/2013 - 01/2002
5Caspase 3 (Caspase-3)IBA
06/2012 - 01/2002
3Proteins (Proteins, Gene)FDA Link
02/2014 - 05/2005
2Sunscreening Agents (Sunscreens)IBA
01/2013 - 01/2007
2AdipokinesIBA
01/2013 - 06/2012
2Pyrimidine DimersIBA
01/2013 - 01/2007
2CoffeeFDA Link
01/2013 - 07/2011
2DNA (Deoxyribonucleic Acid)IBA
01/2013 - 08/2011
2Cyclin B1IBA
07/2011 - 04/2008
2sodium benzoate drug combination caffeineIBA
03/2008 - 01/2007
2CaspasesIBA
09/2002 - 01/2002
2epigallocatechin gallate (epigallocatechin-3-gallate)IBA
09/2002 - 01/2002
1isothiocyanic acidIBA
03/2014
1sulforaphaneIBA
03/2014
1ParaffinIBA
02/2014
1Phosphodiesterase InhibitorsIBA
01/2014
19-(2-hydroxy-3-nonyl)adenine (EHNA)IBA
01/2014
1salicylhydroxamic acid (SHAM)IBA
06/2012
1CytokinesIBA
06/2012
1CholesterolIBA
11/2011
1C-Reactive ProteinIBA
11/2011
1Blood Glucose (Blood Sugar)IBA
11/2011
1Alanine Transaminase (SGPT)IBA
11/2011
1Triglycerides (Triacylglycerol)IBA
11/2011
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2011
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
11/2011
1PolyphenolsIBA
11/2011
1LipidsIBA
11/2011
1Phosphotransferases (Kinase)IBA
08/2011
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
07/2011
1Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA
07/2011
1eucerinIBA
02/2009
1Drinking WaterIBA
07/2007
1Dietary Fats (Dietary Fat)IBA
10/2006
1dibenzoylmethaneIBA
01/2006
1PhytochemicalsIBA
01/2006
1anthraceneIBA
01/2006
1prolyl-serine (Pro-Ser)IBA
05/2005
1Codon (Codons)IBA
05/2005
1prolylleucineIBA
05/2005
1Green OrIBA
08/2002
1Bromodeoxyuridine (BrdU)IBA
01/2002
1Peptide Hydrolases (Proteases)FDA Link
01/2002

Therapy/Procedure

6Oral Administration
01/2013 - 01/2002
2Aftercare (After-Treatment)
08/2005 - 07/2004
1Fat-Restricted Diet (Diet, Fat Restricted)
07/2014
1Lipectomy (Liposuction)
06/2012
1Topical Administration
03/2008